FDA Approved: REGADENOSON — Original Application (Meitheal Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Meitheal Pharmaceuticals' original (ANDA) application for Regadenoson, a generic pharmacologic stress agent used for myocardial perfusion imaging.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease

Drugs mentioned

• Regadenoson (Regadenoson)

Snippet

ORIG AP for REGADENOSON (REGADENOSON)